Bluebird is pretty chirpy about its anti-BCMA CAR-T therapy results – MedCity News
|
Bluebird is pretty chirpy about its anti-BCMA CAR–T therapy results
MedCity News You know you're on to something worthwhile when your study leader can't quite hold back the tears when presented with the final data. That was the case with Bluebird Bio's first major clinical trial for its experimental anti-BCMA CAR–T cell therapy in … |
